299 related articles for article (PubMed ID: 22247554)
1. Characterizing phospholamban to sarco(endo)plasmic reticulum Ca2+-ATPase 2a (SERCA2a) protein binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking.
Akin BL; Jones LR
J Biol Chem; 2012 Mar; 287(10):7582-93. PubMed ID: 22247554
[TBL] [Abstract][Full Text] [Related]
2. Role of leucine 31 of phospholamban in structural and functional interactions with the Ca2+ pump of cardiac sarcoplasmic reticulum.
Chen Z; Stokes DL; Jones LR
J Biol Chem; 2005 Mar; 280(11):10530-9. PubMed ID: 15644311
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2007 Jul; 282(29):20968-76. PubMed ID: 17548345
[TBL] [Abstract][Full Text] [Related]
4. Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
Ferrandi M; Barassi P; Tadini-Buoninsegni F; Bartolommei G; Molinari I; Tripodi MG; Reina C; Moncelli MR; Bianchi G; Ferrari P
Br J Pharmacol; 2013 Aug; 169(8):1849-61. PubMed ID: 23763364
[TBL] [Abstract][Full Text] [Related]
5. Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2010 Jan; 285(5):3253-60. PubMed ID: 19948724
[TBL] [Abstract][Full Text] [Related]
6. Superinhibitory phospholamban mutants compete with Ca2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state.
Akin BL; Chen Z; Jones LR
J Biol Chem; 2010 Sep; 285(37):28540-52. PubMed ID: 20622261
[TBL] [Abstract][Full Text] [Related]
7. Close proximity between residue 30 of phospholamban and cysteine 318 of the cardiac Ca2+ pump revealed by intermolecular thiol cross-linking.
Jones LR; Cornea RL; Chen Z
J Biol Chem; 2002 Aug; 277(31):28319-29. PubMed ID: 12015326
[TBL] [Abstract][Full Text] [Related]
8. Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents.
Chen Z; Stokes DL; Rice WJ; Jones LR
J Biol Chem; 2003 Nov; 278(48):48348-56. PubMed ID: 12972413
[TBL] [Abstract][Full Text] [Related]
9. The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum.
Akin BL; Hurley TD; Chen Z; Jones LR
J Biol Chem; 2013 Oct; 288(42):30181-30191. PubMed ID: 23996003
[TBL] [Abstract][Full Text] [Related]
10. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition.
Mahaney JE; Albers RW; Waggoner JR; Kutchai HC; Froehlich JP
Biochemistry; 2005 May; 44(21):7713-24. PubMed ID: 15909986
[TBL] [Abstract][Full Text] [Related]
11. Cross-linking of C-terminal residues of phospholamban to the Ca2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain.
Chen Z; Akin BL; Stokes DL; Jones LR
J Biol Chem; 2006 May; 281(20):14163-72. PubMed ID: 16554295
[TBL] [Abstract][Full Text] [Related]
12. Competitive displacement of wild-type phospholamban from the Ca2+-free cardiac calcium pump by phospholamban mutants with different binding affinities.
Chen Z
J Mol Cell Cardiol; 2014 Nov; 76():130-7. PubMed ID: 25194792
[TBL] [Abstract][Full Text] [Related]
13. Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure.
Currie S; Smith GL
Cardiovasc Res; 1999 Jan; 41(1):135-46. PubMed ID: 10325961
[TBL] [Abstract][Full Text] [Related]
14. The transmembrane peptide DWORF activates SERCA2a via dual mechanisms.
Li A; Yuen SL; Stroik DR; Kleinboehl E; Cornea RL; Thomas DD
J Biol Chem; 2021; 296():100412. PubMed ID: 33581112
[TBL] [Abstract][Full Text] [Related]
15. A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span.
Vangheluwe P; Tjwa M; Van Den Bergh A; Louch WE; Beullens M; Dode L; Carmeliet P; Kranias E; Herijgers P; Sipido KR; Raeymaekers L; Wuytack F
J Mol Cell Cardiol; 2006 Aug; 41(2):308-17. PubMed ID: 16814319
[TBL] [Abstract][Full Text] [Related]
16. Phospholamban and sarcolipin: Are they functionally redundant or distinct regulators of the Sarco(Endo)Plasmic Reticulum Calcium ATPase?
Shaikh SA; Sahoo SK; Periasamy M
J Mol Cell Cardiol; 2016 Feb; 91():81-91. PubMed ID: 26743715
[TBL] [Abstract][Full Text] [Related]
17. Association with SERCA2a directs phospholamban trafficking to sarcoplasmic reticulum from a nuclear envelope pool.
He W; Huang D; Guo S; Wang D; Guo J; Cala SE; Chen Z
J Mol Cell Cardiol; 2020 Jun; 143():107-119. PubMed ID: 32353354
[TBL] [Abstract][Full Text] [Related]
18. A phospholamban-tethered cardiac Ca2+ pump reveals stoichiometry and dynamic interactions between the two proteins.
Chen Z
Biochem J; 2011 Oct; 439(2):313-9. PubMed ID: 21728996
[TBL] [Abstract][Full Text] [Related]
19. Phospholamban modulates the functional coupling between nucleotide domains in Ca-ATPase oligomeric complexes in cardiac sarcoplasmic reticulum.
Chen LT; Yao Q; Soares TA; Squier TC; Bigelow DJ
Biochemistry; 2009 Mar; 48(11):2411-21. PubMed ID: 19191503
[TBL] [Abstract][Full Text] [Related]
20. Sarcolipin protein interaction with sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) is distinct from phospholamban protein, and only sarcolipin can promote uncoupling of the SERCA pump.
Sahoo SK; Shaikh SA; Sopariwala DH; Bal NC; Periasamy M
J Biol Chem; 2013 Mar; 288(10):6881-9. PubMed ID: 23341466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
